Ulrich Knigge
Guest researcher
Cluster for Molecular Imaging
Blegdamsvej 3, 2200 København N.
1 - 1 out of 1Page size: 10
- 2011
- Published
Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas
Olsen, I. H., Federspiel, B., Kjær, Andreas, Hansen, C. P., Knigge, Ulrich & Langer, Seppo W., 2011, p. 38-38. 1 p.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
ID: 916819
Most downloads
-
789
downloads
Down-regulation of miR-129-5p and the let-7 family in neuroendocrine tumors and metastases leads to up-regulation of their targets Egr1, G3bp1, Hmga2 and Bach1
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
463
downloads
PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature
Research output: Contribution to journal › Review › Research › peer-review
Published -
155
downloads
Somatostatin analogue treatment primarily induce miRNA expression changes and up-regulates growth inhibitory miR-7 and miR-148a in neuroendocrine cells
Research output: Contribution to journal › Journal article › Research › peer-review
Published